cyclam has been researched along with naphthalimides in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rutledge, PJ; Todd, MH; Yu, M; Yu, Q | 1 |
| Chen, Z; Ding, J; Han, K; Li, Q; Qian, X; Tan, S; Tong, L; Xie, H; Xu, Y; Yang, Y | 1 |
| Chen, Z; Li, H; Li, Q; Liu, J; Lyu, J; Qian, X; Sun, D; Sun, X; Tan, S; Wang, X; Wu, F; Xu, Y; Yang, Y | 1 |
3 other study(ies) available for cyclam and naphthalimides
| Article | Year |
|---|---|
A fluorescent "allosteric scorpionand" complex visualizes a biological recognition event.
Topics: Avidin; Biotin; Coordination Complexes; Fluorescent Dyes; Heterocyclic Compounds; Naphthalimides; Protein Binding; Spectrometry, Fluorescence; Zinc | 2013 |
Novel metal complexes of naphthalimide-cyclam conjugates as potential multi-target receptor tyrosine kinase (RTK) inhibitors: synthesis and biological evaluation.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chemistry Techniques, Synthetic; Down-Regulation; Drug Screening Assays, Antitumor; Heterocyclic Compounds; Humans; Naphthalimides; Organometallic Compounds; Protein Kinase Inhibitors; Receptor Protein-Tyrosine Kinases; Signal Transduction; Structure-Activity Relationship | 2014 |
Antiproliferative and apoptosis-inducing activities of novel naphthalimide-cyclam conjugates through dual topoisomerase (topo) I/II inhibition.
Topics: Apoptosis; Heterocyclic Compounds; Humans; Molecular Structure; Naphthalimides; Topoisomerase II Inhibitors | 2015 |